SANA BIOTECHNOLOGY INC (SANA) Stock Income Statement
NASDAQ:SANA • US7995661045
Current stock price
2.77 USD
-0.26 (-8.58%)
At close:
2.82 USD
+0.05 (+1.81%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 205.71M | 272.72M | 293.14M | 272.56M | 356.91M | |||
| Research and Development | 131.98M | 217.56M | 268.82M | 285.89M | 248.63M | |||
| Selling, General, and Administrative Expenses | 44.30M | 64.04M | 73.30M | 71.56M | 50.41M | |||
| Operating Income | -205.71M | -272.72M | -293.14M | -272.56M | -356.91M | |||
| Interest Income/Expense | 3.85M | 10.47M | 9.94M | 3.76M | 680.00K | |||
| Other Income/Expense | 2.31M | -4.51M | -52.00K | -670.00K | 310.00K | |||
| Non Recurring Items | -44.61M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -244.17M | -266.76M | -283.25M | -269.48M | -355.93M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -244.17M | -266.76M | -283.25M | -269.48M | -355.93M | |||
| EBITDA | -192.96M | -255.33M | -268.58M | -256.93M | -345.84M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 | |||
| Non GAAP EPS | -0.79 | -1.16 | -1.41 | -1.69 | -1.83 | |||
| Statistics | ||||||||
All data in USD